- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Commentary
Article
Closing Out AAD With Dermatology Times’ Editor in Chief
Author(s):
Christopher Bunick, MD, PhD, shares concluding remarks with colleagues at AAD 2025.
A message from Dermatology Times’ Editor in Chief, Christopher Bunick, MD, PhD: I'm really excited by the content that we've been able to bring to you at the American Academy of Dermatology Meeting. We learn so much here, and what we've tried to do at Dermatology Times is to highlight some of the most important things that will help you in your practice better care for your patients, elevate patient standard of care, and make you comfortable as a provider in understanding the knowledge, the science, and the practical aspects of what you need to do to take care of your patients.
On behalf of Dermatology Times, thank you so much for listening to our content, watching our content, and reading our content as we continue to try to bring the best education and the most relevant education to you every day, every week, all year long.
Christopher Bunick, MD, PhD, is an associate professor of dermatology and translational biomedicine at Yale School of Medicine in New Haven, Connecticut.
